Results 181 to 190 of about 51,073 (294)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia [PDF]

, 2008
Baojin Zhu, Haya Ascher‐Svanum, Douglas E. Faries, Christoph U. Correll, John M. Kane   +4 more
openalex   +1 more source

Development of a Novel Frailty Trigger for Use at Triage in the Emergency Department

Academic Emergency Medicine, EarlyView.
ABSTRACT Background Emergency Department (ED) Triage identifies patients with urgent needs. Frailty is not routinely identified and older patients presenting atypically may be inappropriately triaged as low priority. The introduction of a frailty modifier at triage is recommended in international guidelines, but is not yet widely‐adopted.
Elizabeth Moloney, Mark R. O'Donovan, Dearbhla Burke, Anne Healy, Maria Larkin, Anne O'Keeffe, Rónán O'Caoimh   +6 more
wiley   +1 more source

Polypharmacy and Inappropriate Medication Use in Singapore Nursing Homes

, 2004
K Mamun, Christopher Lien, C Y E Goh-Tan, WST Ang   +3 more
openalex   +2 more sources

The dilemma of polypharmacy [PDF]

, 2008
Sarah N. Hilmer
openalex   +1 more source

Predicting Cognitive Change During Treatment for Inpatient Depression: Secondary Analysis From a Randomized Controlled Trial

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Individuals hospitalized with depression are particularly impacted by cognitive impairment. Identifying variables that predict improvements in cognition across treatment may inform more targeted and effective treatment approaches. We conducted secondary analyses to investigate baseline predictors of objective cognitive change in a
Zoe A. Odering, Jennifer Jordan, Cameron J. Lacey, Christopher M. Frampton, Richard J. Porter, Katie M. Douglas   +5 more
wiley   +1 more source

Psychotropic Polypharmacy and Related Factors in Children and Adolescents. [PDF]

Psychiatry Investig
Özbek MM, Atay E, Sevinçok D, Özbay HC, Özbek TC, Cansız MA.   +5 more
europepmc   +1 more source

Medical Therapy in Heart Failure – Is Polypharmacy Necessary?

, 2004
BWK Kwok
openalex   +2 more sources

Efficacy and Acceptability of Licensed and Off‐Label Pharmacological Interventions for Insomnia in Patients With Severe Mental Illness: A Systematic Review and Meta‐Analysis of Randomised Trials

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background A wide range of drugs is used to alleviate insomnia symptoms in individuals with severe mental illness (SMI), including licensed drugs and sedating drugs prescribed off‐label. Yet, no review has gathered the evidence on illness‐specific or transdiagnostic outcomes of pharmacological interventions for insomnia.
Nina Friis Bak Fuglsang, Nanna Marker Madsen, Søren Lundorff Jacobsen, Julie Eg Frøkjær, Nicolai Ladegaard, Marc Alberg Sørensen, Christoph U. Correll, Christian Otte, Mikkel Højlund, Ole Köhler‐Forsberg   +9 more
wiley   +1 more source

Polypharmacy: saint or sinner? [PDF]

, 2010
Deji Odelola, Nadezda Ranceva
openalex   +1 more source

Unpacking the link between substance use disorders and 30‐day unplanned readmission

Addiction, EarlyView.
Abstract Background and Aims Given the more than twofold increase in the prevalence of substance use disorders in the United States in the past decade, more hospital inpatients can be expected to carry substance use disorder diagnoses, necessitating evaluation of potential links to 30‐day unplanned readmissions, a marker of quality of care.
Allison D. Rosen, Sae Takada, Catherine Juillard, Yulsi L. Fernandez Montero, Amy M. Richards, Serge Ngekeng, Steven J. Shoptaw, Michelle A. Bholat   +7 more
wiley   +1 more source